BC
LLY icon

Burleson & Co’s Eli Lilly LLY Stock Holding History

Burleson & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$9.5M Buy
25,979
+232
+0.9% +$82.3K 2.37% 10
2022
Q3 		$8.32M Buy
25,747
+295
+1% +$93.5K 1.79% 16
2022
Q2 		$8.25M Sell
25,452
-339
-1% -$102K 1.79% 15
2022
Q1 		$7.39M Buy
25,791
+9,977
+63% +$2.57M 1.19% 25
2021
Q4 		$4.37M Sell
15,814
-1,099
-6% -$279K 0.64% 34
2021
Q3 		$3.91M Hold
16,913
– – 0.58% 36
2021
Q2 		$3.88M Buy
16,913
+75
+0.4% +$15.1K 0.57% 40
2021
Q1 		$3.15M Hold
16,838
– – 0.51% 37
2020
Q4 		$2.84M Hold
16,838
– – 0.49% 38
2020
Q3 		$2.4M Hold
16,838
– – 0.45% 43
2020
Q2 		$2.58M Hold
16,838
– – 0.56% 40
2020
Q1 		$2.58M Sell
16,838
-42
-0.2% -$5.77K 0.67% 41
2019
Q4 		$2.39M Buy
16,880
+1
+0% +$116 0.67% 41
2019
Q3 		$1.81M Hold
16,879
– – 0.63% 44
2019
Q2 		$1.86M Hold
16,879
– – 0.79% 37
2019
Q1 		$1.97M Hold
16,879
– – 0.84% 35
2018
Q4 		$2.07M Sell
16,879
-53
-0.3% -$5.92K 1.07% 25
2018
Q3 		$1.96M Sell
16,932
-422
-2% -$42.2K 1.1% 24
2018
Q2 		$1.48M Sell
17,354
-163
-0.9% -$13.4K 0.86% 38
2018
Q1 		$1.35M Buy
17,517
+4
+0% +$322 0.88% 40
2017
Q4 		$1.48M Buy
+17,513
New +$1.49M 0.95% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Burleson & Co's LLY Position: Q4 2022 in Review

Burleson & Co increased its Eli Lilly (LLY) stake by 0.9% in Q4 2022, buying an estimated $82.3K and bringing the position to 25,979 shares worth $9.5M. The position accounts for 2.37% of the portfolio, ranked #10.

Burleson & Co first reported a position in LLY in Q4 2017 and has held it in 21 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Burleson & Co held 25,979 shares of Eli Lilly worth $9.5M as of Q4 2022.
  • Burleson & Co bought 232 Eli Lilly shares in Q4 2022, an estimated $82.3K.
  • Eli Lilly made up 2.37% of Burleson & Co's portfolio in Q4 2022, its #10 holding.
  • Burleson & Co first reported a position in Eli Lilly in Q4 2017 and has held it in 21 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.